Merck
HomeApplicationsPharmaceutical & Biopharmaceutical ManufacturingPharma & Biopharma Startup HubPre-clinical

Pre-clinical

Pre-clinical phase

Pre-clinical testing establishes that the target compound is safe and effective before it can be tested in humans, in preparation for filing an Investigational New Drug (IND) application. Considerations during the pre-clinical stage include:

  • Detailed material properties
  • Detailed in vitro safety testing
  • Expand in vivo safety testing
  • Process development

Biotech Resources

Talk: The Search for Funding: What you Should Prepare Prior to Your Pitch
Talk: Emerging Biopharma Companies Need more than Just Lab Space from Biotech Hubs
Technical Article: Navigating The Regulatory Maze: Fundamentals for Drug Development
FDA Investigational New Drug (IND) Application
Emerging BioTalk Blog
Brochure: Integrated Bioprocess Solutions
Biopharmaceutical Application Guide

Toxicology testing services are critically important. A broad spectrum of in vitro and in vivo toxicology testing is required and must be designed in accordance with international guidelines, conducted in full compliance with good laboratory practice (GLP) regulations.

Process Development Considerations

  • Cell line development
  • Clone selection
  • Media and feed screening
  • Upstream process development
  • Master cell bank establishment
  • Downstream process development
  • Formulation development
  • Analytical methods development and optimization
  • Analytical process development support
  • Biosimilars comparability analytical programs
Infographic of BioReliance® cell line development services during pre-clinical phase of new drug investigation

Cell Line Development Considerations

  • Clone choice – lines that can produce the biologic at a high enough titer and quality are essential
  • Robustness studies – best practice to perform studies that replicate the conditions of scale-up
  • Genetic stability – protein production and quality should remain stable after >60 generations of cells

Process Development Considerations

  • Process efficiency – eliminating wasteful steps and optimizing multi-work areas and capacity utilization
  • Process viability – must reliably reproduce through scale-up and tech transfer to another operation
  • Financial viability – balancing productivity with cost for overall financial viability
Infographic of considerations affecting the pre-clinical phase of new drug development

Technology Considerations

  • Flexibility can reduce cost of goods – single-use equipment enhances flexibility, templating, and rapid suite configuration, and reduces cleaning costs
  • Scalability is key – when choosing technologies at the earliest stages, such as scaling a bioreactor used for mammalian cell culture from 3 L to 200 L to 2000 L
  • Evaluate for ease of use – solutions include pre-assembled sterile process flow paths; connectors that allow for aseptic connection, disconnection, and re-connection

Regulatory Considerations

  • Patient safety – as a priority, clinical development milestones must assess safety and product effectiveness
  • Product quality and process robustness – data collection and analysis should happen in parallel with process development
  • Dialog with regulatory authorities – knowing the countries where filing will happen should guide who inspects the manufacturing facility

Business Considerations

  • Speed to clinic – heavy investments are being made in research and development without returns
  • Process efficiency – must proactively consider scale-up later down the line, not just speed early on
  • Filing strategy – to identify the right country to file in first and obtain access to the market quickly

The right resources allow you to focus on discovering innovations that may help patients in need. Select any stage of the development process to learn more. Or follow the product and service links for supportive resources offering plug-and-play opportunities at the beginning of your startup creation.

Biotech Hub Resources Workflow

Biotech Resource Hub

Biotech Resource Hub

Starting your journey to successful drug discovery, development, and commercialization

Discovery

Identifying the considerations, resources, and support you need to develop a new biologics candidate

Phase I–II

Accelerating your process development with tips, templates, and application guides

Phase III and Manufacturing

Progressing from scale-up and tech transfer to quality production for trials and commercialization

Startup Programs

Connecting with resources and grant programs that can unlock your molecule’s potential

Regulatory

Navigating one of the world’s most regulated industries starts with a trusted guide

Related Product Categories

Bioprocessing Cell Culture
Browse our cell culture products for manufacturing, including our cell culture media, cell culture ingredients and supplements, bioreactors, and clarification filters.
Buffer & Media Prep
Explore our solutions for process solution buffer and media preparation, including our Mobius® single-use mixing and Mobius® FlexReady solutions.
Chromatography
Downstream purification in bioprocessing includes one or more chromatographic separation steps to purify your molecule and remove impurities. Our broad chromatography portfolio includes resins, membranes, columns, and systems that work seamlessly together to simplify your workflow from process development to production scale.

Related Applications

Gene Therapy Manufacturing
Growing use of gene therapies is driving rapid innovation in an evolving global market. Manufacturers bringing new gene therapies to life face complex challenges, requiring an experienced partner capable of integrating vector manufacturing, testing, safety, process development, and regulatory compliance.
Cell Therapy Manufacturing
Introducing a new cell therapy demands optimal performance in upstream and downstream processing, process development, testing, and manufacturing. World-class products and partners are critical to success, speeding advancement of therapeutics that are effective, safe, and affordable.
Monoclonal Antibody Manufacturing
Monoclonal antibody manufacturing is a highly templated approach used to produce mAb-based immunotherapies. Robust, scalable process solutions are required at every step to ensure high therapeutic concentration and process safety, while meeting speed-to-market and cost containment concerns.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Antibody-Drug Conjugate (ADC) Manufacturing
Antibody-drug conjugation (ADC) technology uses monoclonal antibodies (mAbs) to deliver potent, highly active pharmaceutical ingredients (HPAPIs) to targeted cells. Learn about processes and areas of expertise required to advance your ADC to market.
Classical Pharmaceutical Formulation & Manufacturing
Manufacturing the final dosage form of a small molecule drug requires robust quality and design in development of the formulation and production of the final product. Explore solutions and best practices to advance and accelerate small molecule pharmaceuticals, from development to commercialization.

RELATED SERVICES

Analytical Development and Product Characterization
Choosing the right partner for your biologics analytical development is critical in the approval race. Our BioReliance® product characterization services will help move your molecule from concept to clinic to commercial.
Contract Manufacturing
Reduce risk, remain compliant and accelerate development and manufacturing timelines by working with a single, trusted partner for all your API, mAbs, Viral Vecdtor & contract manufacturing needs.
Emprove® Program
Confidently speed your way through the regulatory maze and fast track your new drug to market with the Emprove® Program. High-quality products, comprehensive documentation, and superior customer support facilitate your efforts in qualification, risk assessment, and process optimization.
Validation Services
Validation Services
Testing
We are a leading provider of contract services in the biopharmaceutical industry, supporting every phase of the testing, development and manufacturing process and offering a comprehensive and integrated package of services.
M Lab™ Collaboration Centers
M Lab™ Collaboration Centers offer in-person or virtual visits with experts to solve the challenges in your biopharma and pharma facilities. From upstream to downstream and through the final fill, our non-GMP facilities are resource hubs where you can explore, learn, and collaborate.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?